Skip to main content
Clinical Trials/CTRI/2025/09/095413
CTRI/2025/09/095413
Not yet recruiting
Not Applicable

A clinical study to evaluate the effectiveness of the test product on the tanned skin along with its safety on healthy adult female participants.

Zydus Wellness Products Limited1 site in 1 country36 target enrollmentStarted: October 22, 2025Last updated:

Overview

Phase
Not Applicable
Status
Not yet recruiting
Enrollment
36
Locations
1
Primary Endpoint
To assess the efficacy of test product on tanned skin, based on instrumental evaluations.

Overview

Brief Summary

This is an open label, non-randomized, single-center, single-arm clinical study to evaluate the effectiveness of the test product on the tanned skin along with its safety on healthy adult female participants.

The potential participants will be screened as per the inclusion and exclusion criteria only after obtaining written informed consent from the participants.

All eligible participants will undergo clinical evaluation by a Dermatologist, instrument evaluation and subjective evaluation. Safety will be assessed throughout the study by monitoring adverse events.

Study Design

Study Type
Interventional
Allocation
Na
Masking
None

Eligibility Criteria

Ages
18.00 Year(s) to 45.00 Year(s) (—)
Sex
Female

Inclusion Criteria

  • Non-pregnant /non-lactating females.
  • Participants with fitzpatrick skin type IV and V.
  • Participants with visible skin tan on face, at least 2 shade darker than a Sun protected upper volar arm.
  • Participants with at least 2 blemishes.
  • Participants who are willing to voluntarily participate in the study and provide signed informed consent.

Exclusion Criteria

  • Participants with dark facial skin as determined by dermatologist.
  • Participants having any active dermatological skin diseases (e.g., psoriasis, atopic dermatitis, rosacea etc.), that might interfere with clinical assessments.
  • Participants using any other facewash during the study period.
  • Participants using other marketed skin lightening products during the study period or in the past 6 weeks.
  • Participants who are receiving topical or systemic treatments for pigmentation within the last 30 days.
  • Participant undergoing treatment for Seborrhoea, Acne, Dermatitis, Melasma, Lentigines, skin Lightening/ any other cosmetic/ dermatologic skin condition on face.

Outcomes

Primary Outcomes

To assess the efficacy of test product on tanned skin, based on instrumental evaluations.

Time Frame: Day 01 (Before and after product usage) , Day 03, Day 07, Day 14 and Day 21.

Secondary Outcomes

  • To assess the efficacy of test product on tanned skin, based on clinical, instrumental and subjective evaluations.(Day 01 (Before and after product usage) , Day 03, Day 07, Day 14 and Day 21.)

Investigators

Sponsor Class
Other [Health and Hygiene]
Responsible Party
Principal Investigator
Principal Investigator

Dr Bhagirath Patel

Cliantha Research

Study Sites (1)

Loading locations...

Similar Trials